Octreotate-Lu-177-DOTA-Tyr-3/yttrium-90-DOTATOC: Acute myeloid leukaemia: case report

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1401, 2012-01, pp. : 28-29

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Octreotate-Lu-177-DOTA-Tyr-3: First report of hormonal crises: 6 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1207, 2008-01 ,pp. : 26-27

Adis International

Access to resources Recommend Favorite

Lu-177-octreotide/yttrium-90-DOTATOC: Acute myeloid leukaemia: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1415, 2012-01 ,pp. : 32-33

Adis International

Access to resources Recommend Favorite

[177Lu]-DOTA0-Tyr3-Octreotate: A Potential Targeted Radiotherapeutic for the Treatment of Medulloblastoma

By  

Current Radiopharmaceuticals, Vol. 3, Iss. 1, 2010-01 ,pp. : 29-36

Bentham Science Publishers

Access to resources Recommend Favorite

Cytarabine/etoposide/ibritumomab tiuxetan Y-90: Treatment-related acute myeloid leukaemia?: case report

By  

Reactions Weekly, Vol. 1, Iss. 1295, 2010-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Ibritumomab tiuxetan Y-90: Acute myeloid leukaemia in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1230, 2008-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite